In Vivo Gene Delivery with l-Tyrosine Polyphosphate Nanoparticles
- 8 April 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 10 (5) , 1836-1844
Abstract
The concept of gene therapy is promising; however, the perceived risks and side effects associated with this technology have severely dampened the researchers’ enthusiasm.(1-3) Thus, the development of a nonviral gene vector without immunological effects and with high transfection efficiency is necessary. Currently, most nonviral vectors have failed to achieve the in vivo transfection efficiencies of viral vectors due to their toxicity,(4) rapid clearance,(5, 6) and/or inappropriate release rates.(7) Although our previous studies have successfully demonstrated the controlled-release of plasmid DNA (pDNA) polyplexes encapsulated into nanoparticles formulated with l-tyrosine polyphosphate (LTP-pDNA nanoparticles),(8, 9) the in vivo transfection capabilities and immunogenicity of this delivery system have yet to be examined. Thus, we evaluate LTP-pDNA nanoparticles in an in vivo setting via injection into rodent uterine tissue. Our results demonstrate through X-gal staining and immunohistochemistry of uterine tissue that transfection has successfully occurred after a nine-day incubation. In contrast, the results for the control nanoparticles show results similar to those of shams. Furthermore, reverse transcriptase polymerase chain reaction (RT-PCR) from the injected tissues confirms the transfection in vivo. To examine the immunogenicity, the l-tyrosine polyphosphate (LTP) nanoparticles have been evaluated in a mouse model. No significant differences in the activation of the innate immune system are observed. These data provide the first report for the potential use of controlled-release nanoparticles formulated from an amino acid based polymer as an in vivo nonviral vector for gene therapy.Keywords
This publication has 52 references indexed in Scilit:
- Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membraneProceedings of the National Academy of Sciences, 2012
- Non-viral gene delivery nanoparticles based on Poly(β-amino esters) for treatment of glioblastomaBiomaterials, 2011
- Dual‐Sensitive Micellar Nanoparticles Regulate DNA Unpacking and Enhance Gene‐Delivery EfficiencyAdvanced Materials, 2010
- Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsionsInternational Journal of Pharmaceutics, 2010
- Gene therapy: back on track?EMBO Reports, 2010
- Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene deliveryJournal of The Royal Society Interface, 2009
- Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsProceedings of the National Academy of Sciences, 2009
- Efficient Non-Viral Ocular Gene Transfer with Compacted DNA NanoparticlesPLOS ONE, 2006
- A Look to Future Directions in Gene Therapy Research for Monogenic DiseasesPLOS Genetics, 2006
- Properties of l-tyrosine based polyphosphates pertinent to potential biomaterial applicationsPolymer, 2005